In this study, we were able to demonstrate that shRNA-mediated inhibition of PLK1 in the melanoma cell lines (A375 and SK-MEL-2) inhibited the NOTCH pathway by decreasing the expression of NICD (NOTCH intracellular domain), as well as its nuclear intensity. The gene discussed is PLK1; the disease is melanoma.